Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Qiagen (1QGEN) Stock Price & Analysis

0 Followers

1QGEN Stock Chart & Stats

€45.30-€0.06(-0.14%)
At close: 5:30 PM GMT+1
€37.5€40€42.5€45Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
EUR 45.20 - EUR 45.31
52-Week Range
EUR 15.00 - EUR 64.00
Previous Close
EUR 45.36
Volume
N/A
Average Volume (3M)
438
Market Cap
EUR 9.39B
Enterprise Value
EUR 9.92B
Total Cash (Recent Filing)
EUR 830.13M
Total Debt (Recent Filing)
EUR 1.64B
Price to Earnings (P/E)
26.9
Beta
0.02
Next Earnings
Feb 09, 2027 (Est.)
EPS Estimate
0.59
Next Dividend Ex-Date
N/A
Dividend Yield
5.14%

Bulls Say, Bears Say

Bulls Say

Recurring Consumables Model

The high share of consumables and related revenue gives QIAGEN a recurring demand base tied to customers’ ongoing testing and research activity. This supports revenue visibility, creates workflow pull-through for instruments, and can make the business more resilient than one dependent mainly on episodic equipment sales.

Growth Pillar Momentum

Growth across several strategic pillars indicates that expansion is not reliant on a single product or end market. Sample Technologies, QIAcuity, and digital insights can broaden QIAGEN’s platform, strengthen customer workflows, and provide durable avenues for growth as new products are adopted.

Positive Cash Generation

Substantial operating and free cash flow gives QIAGEN internal funding capacity for research, product launches, strategic investment, and shareholder returns. Although recent cash-flow momentum is softer, the positive cash base remains an important support for business resilience and capital allocation over coming quarters.

Bears Say

Transaction-Driven Uncertainty

Suspending guidance because of the pending transaction reduces visibility into near-term operating expectations and places execution within a changing ownership framework. Governance, capital allocation, and strategic priorities may shift before completion, creating uncertainty for employees, partners, and ongoing business planning.

Weakness In PCR And QIAstat

Declines in QIAstat and PCR show that important product groups remain under pressure even while selected growth pillars perform well. Persistent weakness could dilute portfolio growth, reduce operating leverage, and require additional commercial or product investment to restore demand across these franchises.

Inventory And Cash Conversion Pressure

The inventory build ties up cash and raises execution risk if new product launches take longer than expected to scale. Higher working-capital requirements can limit free-cash-flow conversion and increase the need for disciplined forecasting, especially alongside already modest recent cash-flow momentum.

Qiagen News

1QGEN FAQ

What was Qiagen’s price range in the past 12 months?
Qiagen lowest stock price was €15.00 and its highest was €64.00 in the past 12 months.
What is Qiagen’s market cap?
Qiagen’s market cap is €9.39B.
When is Qiagen’s upcoming earnings report date?
Qiagen’s next earnings report is estimated for Feb 09, 2027 (not yet confirmed), which is in 87 days.
How were Qiagen’s earnings last quarter?
Qiagen released its earnings results on Nov 04, 2026. The company reported €0.582 earnings per share for the quarter, beating the consensus estimate of €0.561 by €0.021.
Is Qiagen overvalued?
According to Wall Street analysts Qiagen’s price is currently Undervalued.
Does Qiagen pay dividends?
Qiagen does not currently pay dividends.
What is Qiagen’s EPS estimate?
Qiagen’s EPS estimate is 0.59.
How many shares outstanding does Qiagen have?
Qiagen has 206,496,520 shares outstanding.
What happened to Qiagen’s price movement after its last earnings report?
Qiagen reported an EPS of €0.582 in its last earnings report, beating expectations of €0.561. Following the earnings report the stock price went up 0.088%.
Which hedge fund is a major shareholder of Qiagen?
Hedge funds hold Qiagen shares: the largest hedge-fund position in Qiagen is 520,587,367 shares, and hedge funds increased their holdings by 982.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology